[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349905-105":59,"doc-detail-349905-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","aging-associated-differences-in-mammary-tumorinitiating-populations-and-immune-evasion-pathways-in-breast-cancer","Aging-associated differences in mammary tumor–initiating populations and immune evasion pathways in breast cancer","","Aging is a major breast cancer risk factor, yet its impact on tumor initiation, molecular phenotype, and immune evasion is not fully understood. Using an N-nitroso-N-methylurea (NMU)-induced rat mammary tumor model, the study integrates bulk and single-cell transcriptomics, whole-exome sequencing, and histopathology to map age-associated differences. Age at exposure alters incidence, mutational burden, subtype, and the immune microenvironment, with aged-origin tumors showing immune infiltration loss and impaired antigen presentation. Key chromosomal losses align with conserved findings in human cancers and relate to lymphocyte infiltration and relapse-free survival.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/aging-associated-differences-in-mammary-tumorinitiating-populations-and-immune-evasion-pathways-in-breast-cancer/349905/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/aging-associated-differences-in-mammary-tumorinitiating-populations-and-immune-evasion-pathways-in-breast-cancer/349905.png","ImageObject",300,407,{"name":92,"@type":93},"Miles","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does the age at NMU exposure affect breast tumor outcomes in the rat model?","Question",{"text":112,"@type":113},"Age at exposure changes tumor incidence, mutational burden, molecular subtype, and the tumor immune microenvironment.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What cellular and molecular features characterize tumors arising in aged rats?",{"text":117,"@type":113},"Aged-origin tumors arise from aging luminal progenitor-like cells, show increased genomic instability, reduced immune infiltration, and impaired antigen presentation linked to chromosomal loss of heterozygosity at 20p.",{"name":119,"@type":110,"acceptedAnswer":120},"How are the rat model findings related to human breast cancer?",{"text":121,"@type":113},"Age-associated epithelial and immune changes are conserved in human breast cancers, where loss of the homologous 6p region correlates with reduced lymphocyte infiltration and shorter relapse-free survival.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},349905,1791037494,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},13056703019404,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","RESEARCH ARTICLE  \nMEDICAL SCIENCES  \n OPEN ACCESS  \nAging-associated differences in mammary tumor–initiating populations and immune evasion pathways in breast cancer  \nPengze Yana, b,c , Triet Buia, b,c, Ernesto Rojas Jimeneza, b,c, Yanan Kuangd, Shidong Xud, Cloud P. Paweletzd, Hodaya Haimove, Menachem Sklartze, Ofir Cohene,  \nSandra S. McAllisterb,c, and Kornelia Polyaka, b,c, 1  Affiliations are included on p. 12.  \nContributed by Kornelia Polyak; received August 22, 2025; accepted January 14, 2026; reviewed by James DeGregori and Katerina Politi  \nAging is a major risk factor for breast cancer, yet how it shapes tumor development, molecular phenotype, and immune evasion remains incompletely understood. Deciphering how aging influences cancer evolution is critical for improving risk assessment, prevention, and treatment. Here, using aN-nitroso-N-methylurea (NMU)-induced rat mammary tumor model that recapitulates key features of human breast cancer, we integrated bulk and single-cell transcriptomics, whole-exome sequencing, and histopathological analysis to dissect age-associated differences in mammary tumorigenesis. We found that the age at NMU exposure critically influences tumor incidence, mutational burden, molecular subtype, and the tumor immune microenvironment. Tumors arising in aged rats originated from aging luminal progenitor-like cells, exhibited increased genomic instability, reduced immune cell infiltration, and impaired antigen presentation linked to loss of heterozygosity at chromosome (Chr) 20p. The age-associated epithelial and immune changes we identified were conserved in human breast cancers, where the loss of the homologous Chr 6p region correlated with reduced lymphocyte infiltration and shorter relapse-free survival. These findings reveal that aging profoundly affects tumor-initiating cell populations and promotes immune evasion through chromosomal instability-driven defects in antigen presentation. Our work provides a molecular basis for understanding disease onset and progression that may impact efficacy of immunotherapy in older breast cancer patients.  \naging | breast cancer | immune evasion | chromosomal instability  \nAging is a well-established risk factor for cancer, influencing both tumor initiation and progression through a complex interplay of genetic and epigenetic alterations, decline in systemic immunity, and changes in the tissue microenvironment ( 1) . Breast cancer, the most commonly diagnosed malignancy in women, exhibits significant age-related heterogeneity in its molecular and histopathological characteristics (2) . Despite extensive studies on breast cancer progression, the mechanisms by which aging shapes the tumor cell-of-origin, genetic alterations, and immune evasion remain poorly understood, highlighting the need for longitudinal multiomics studies to map coevolution of cancer epithelium and immune cells throughout different age groups.  \nPrevious studies have demonstrated that aging is associated with increased genomic instability, altered immune surveillance, and changes in extracellular matrix composition, all of which contribute to tumor progression and therapeutic resistance (3, 4) . These changes not only promote tumor growth but also affect responses to immunotherapy and other targeted treatments (3, 5) . However, despite the increasing recognition of these factors, the precise molecular and cellular mechanisms underlying age-associated breast cancer progression remain unclear. Filling this gap in knowledge could help characterize the early stages of tumor development and treatment response, which will aid the design of age-tailored cancer therapies and improved clinical management.  \nWhile human studies have provided insights into age-related transcriptional and mutational alterations, the lack of controlled longitudinal analyses limits our ability to dissect causal mechanisms. Rodent animal models are an ideal experimental model for studying aging and cancer. We and ","cbCaiqpNELuOAzaJ","https://ap.wps.com/l/cbCaiqpNELuOAzaJ","pdf",4077890,12,"English","# Study overview\n## Aging effects on tumor initiation and immune evasion\n## Experimental model and multi-omics integration\n## Conservation of findings in human breast cancer\n## Significance and implications for therapy","[{\"question\":\"How does the age at NMU exposure affect breast tumor outcomes in the rat model?\",\"answer\":\"Age at exposure changes tumor incidence, mutational burden, molecular subtype, and the tumor immune microenvironment.\"},{\"question\":\"What cellular and molecular features characterize tumors arising in aged rats?\",\"answer\":\"Aged-origin tumors arise from aging luminal progenitor-like cells, show increased genomic instability, reduced immune infiltration, and impaired antigen presentation linked to chromosomal loss of heterozygosity at 20p.\"},{\"question\":\"How are the rat model findings related to human breast cancer?\",\"answer\":\"Age-associated epithelial and immune changes are conserved in human breast cancers, where loss of the homologous 6p region correlates with reduced lymphocyte infiltration and shorter relapse-free survival.\"}]","Aging-associated differences in mammary tumor–initiating populations and immune evasion pathways in breast cancer | PDF",1790086176,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bab085fce91639fba8d3e9b5aebe4a0b.webp",983,1316,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/205ebf3c9c25f53fce96276b11c611cd.webp",982,1315,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b2d2d43832b05002bc20930fd4eeb381.webp",981,1313,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b79e9dbf1d8302a5f92ed40ef320f567.webp",980,1312]